Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableNot Yet RecruitingNCT06675994
What this trial is testing

In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme

Who this might be right for
HealthyHypercholesterolemiaHypertension+6 more
LifeBridge Health 80
Not applicableUnknownNCT06115213
What this trial is testing

The North Kynouria Project

Who this might be right for
Cardiovascular DiseasesHeart DiseasesCerebrovascular Disease+7 more
University Hospital, Ioannina 7,000
Not applicableLooking for participantsNCT07334834
What this trial is testing

Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease

Who this might be right for
Hyperlipidemia
Colorado Prevention Center 100
Large-scale testing (Phase 3)Study completedNCT01598948
What this trial is testing

Effect of Mipomersen on LDL-Cholesterol Levels in Patients Treated by Regular Apheresis

Who this might be right for
AtherosclerosisLDL-hypercholesterolemia
Ludwig-Maximilians - University of Munich 17
Post-approval studies (Phase 4)Study completedNCT05192941
What this trial is testing

Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Novartis Pharmaceuticals 1,776
Not applicableStudy completedNCT01642355
What this trial is testing

Prevention Trial to Achieve Cardiovascular Targets

Who this might be right for
Coronary Artery DiseasePeripheral Arterial DiseaseHyperlipidemia+4 more
NYU Langone Health 400
Not applicableStudy completedNCT02341664
What this trial is testing

Patient and Provider Assessment of Lipid Management Registry

Who this might be right for
HyperlipidemiaHypercholesterolemiaCardiovascular Disease+14 more
Duke University 7,658
Not applicableWithdrawnNCT01064934
What this trial is testing

Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a)

Who this might be right for
Hyperlipoproteinemia(a)Progressive Cardiovascular Disease
Charite University, Berlin, Germany
Large-scale testing (Phase 3)Study completedNCT01516541
What this trial is testing

Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

Who this might be right for
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Hoffmann-La Roche 2,220
Not applicableEnrolling By InvitationNCT04929457
What this trial is testing

Evaluation of a Digiphysical Screening Method to Identify and Diagnose Familial Hypercholesterolemia

Who this might be right for
Familial HypercholesterolemiaHypercholesterolemia
Karolinska Institutet 30,000
Not applicableEnded earlyNCT05834673
What this trial is testing

VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Coronary Heart Disease (CHD)Cerebrovascular Disease+1 more
Monash University 6
Not applicableStudy completedNCT01768403
What this trial is testing

Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia

Who this might be right for
HypercholesterolemiaCardiovascular DiseaseHypertension+3 more
AstraZeneca 1,236
Not applicableStudy completedNCT05974345
What this trial is testing

In Silico Study Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Patients With Established Cardiovascular Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 204,691